Zevra Therapeutics, Inc. (ZVRA) Revenue 2018–2025
Zevra Therapeutics, Inc. (ZVRA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$106.5MFY2025 · since FY2018: $0 → $106.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $106.5M | +350.9% |
| FY2024 | $23.6M | -14.0% |
| FY2023 | $27.5M | +170.3% |
| FY2022 | $10.2M | -64.5% |
| FY2021 | $28.6M | +115.6% |
| FY2020 | $13.3M | +3.5% |
| FY2019 | $12.8M | — |
| FY2018 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA Net incomeZVRA Net marginZVRA Gross profitZVRA Gross marginZVRA Operating incomeZVRA Operating marginZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →